.FDA denies psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Authorize MDMA Treatment, Looking For Additional Research The New York TimesFDA Turns Down Ecstasy-Based Medication The Stock market JournalFDA refuses to accept novel MDMA therapy to address post-traumatic stress disorder, along with request for even more hearing information CNNFDA declines to begin with experimental to deal with post-traumatic stress disorder, calling for additional study The Washington Post.